Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings
Neurology
[키워드] Adults
auditory
Baseline assessment
cell line
cell lines
Chloroquine
clinical trials
Compound
conditions
COVID-19
COVID-19 therapeutics
database
drug
Effects
effort
elderly patients
etiology
evaluate
Factor
FDA-approved drug
genetic polymorphisms
hallmark
hearing loss
identify
in silico
in vitro
in vivo
induce
Inflammation
lack
Lopinavir-ritonavir
mammalian
Medicines
novel
novel ototoxins
offer
ototoxic
ototoxicity
over
pandemic
Patient
potentiation
Preclinical
Screening
setting
Side-effect
similarity
subset
synergy
Therapeutic treatment
Therapies
therapy
treat
treating COVID-19
Validity
variety
zebrafish
[DOI] 10.3389/fneur.2021.725566 PMC 바로가기 [Article Type] Neurology
[DOI] 10.3389/fneur.2021.725566 PMC 바로가기 [Article Type] Neurology